Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Biophotonics Market Growth From $103.72 Billion In 2026 To $166.03 Billion By 2030 At A CAGR Of 12.5%
The biophotonics market size has experienced swift expansion in recent years. This market is projected to expand from $92.07 billion in 2025 to reach $103.72 billion by 2026, at a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been driven by advancements in optical sensor technologies, increased funding for life sciences research, the broadening of biomedical imaging applications, a rising adoption of photonic tools in diagnostics, and an overall growth in academic and clinical research.
The biophotonics market is projected to experience substantial expansion in the coming years. Its valuation is forecast to reach $166.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This projected growth during the forecast period is primarily driven by factors such as a heightened demand for precision diagnostics, the broadening scope of personalized medicine applications, the increasing integration of AI in optical imaging, the expanding application of biophotonics in minimally invasive therapies, and the greater uptake of point-of-care diagnostic devices. Key trends anticipated over the forecast period encompass the escalating utilization of optical imaging in diagnostics, the increasing acceptance of non-invasive light-based therapies, the deepening integration of biophotonics into medical devices, the broadening of high-resolution microscopy techniques, and an intensified focus on real-time biological monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Biophotonics Market Demand Drivers: What’s Powering Industry Growth?
The growing demand for minimally invasive surgeries is projected to drive the expansion of the biophotonics market. Optical engineering and imaging technologies are integral to minimally invasive procedures, facilitating real-time visualization of tissue manipulation within distant internal sites. As an illustration, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based non profit professional society, reported that total surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million. Consequently, the rising global volume of minimally invasive surgeries performed annually is contributing to increased revenues in the biophotonics market.
Biophotonics Market Segment Outlook: Which Categories Are Growing Fastest?
The biophotonics market covered in this report is segmented –
1) By Product Technology: In-Vitro, In-Vivo
2) By Application: See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications
3) By End Use: Diagnostics, Therapeutic, Tests, Other End Uses
Subsegments:
1) By In-Vitro: Diagnostic Imaging, Fluorescence Microscopy, Spectroscopy-Based Detection, Biochemical Sensors, Point-Of-Care Devices
2) By In-Vivo: Endoscopy, Optical Coherence Tomography (OCT), Photodynamic Therapy (PDT), Bioluminescence Imaging, Near-Infrared Spectroscopy (NIRS)
Biophotonics Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the biophotonics market are concentrating on developing innovative products such as bronchoscopes, which facilitate advanced medical procedures. These instruments are vital for examining the interior of the respiratory system. For example, in September 2025, Olympus Corporation, a Japan-based manufacturer of precision optics and medical devices, introduced the BF-UCP190F. This new endobronchial ultrasound (EBUS) bronchoscope is specifically optimized for lung lesion biopsy and sophisticated diagnostic procedures. The device features a slender 5.9 mm outer diameter and 170° upward angulation, allowing medical professionals to navigate deeply into the peribronchial region and enhance access to segmental and subsegmental airways. This launch strengthens Olympus’ biophotonics portfolio by integrating optical imaging with real-time ultrasound guidance, thereby addressing the rising demand for minimally invasive lung sampling and improving diagnostic accuracy in thoracic oncology.
Biophotonics Market Leading Companies And Competitive Benchmarking
Major companies operating in the biophotonics market are Thermo Fisher Scientific Inc., OpGen Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co., Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments Plc, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Bioptics Inc.
View The Full Biophotonics Market Report:
Biophotonics Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the biophotonics market in 2025. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









